Diabetic Foot Ulcers Clinical Trial
Official title:
Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing
Many spinal cord injury (SCI) and otherwise debilitated patients develop pressure ulcers
over the course of their injury or disease. Despite enhanced wound care management, many
pressure ulcers do not heal completely and require surgical myocutaneous rotational flap
coverage. Even then they often recur.
The objectives of this study are: (1) to conduct a controlled comparative study of the
effectiveness of subatmospheric pressure dressing (SPD) in healing pressure ulcers versus
conventional saline wet-to-moist dressing techniques; (2) to establish indications and
contra-indications for use of SPD In treating pressure ulcers; and (3) to develop a
noninvasive, clinically usable optical digitizer and associated software for measurement of
wound geometry for standardized quantitative assessment and longitudinal monitoring of wound
healing.
Many spinal cord injury (SCI) and otherwise debilitated patients develop pressure ulcers
over the course of their injury or disease. Despite enhanced wound care management, many
pressure ulcers do not heal completely and require surgical myocutaneous rotational flap
coverage. Even then they often recur.
HYPOTHESIS: Subatmospheric pressure dressing (SPD) treatment applied to pressure ulcers will
either completely close them, or heal to a point allowing for skin graft coverage, more
often than 0.9% normal saline wet-to-moist dressing (WTMD) treatment.
OBJECTIVES: The objectives of this study are: (1) to conduct a controlled comparative study
of the effectiveness of subatmospheric pressure dressing (SPD) in healing pressure ulcers
versus conventional saline wet-to-moist dressing techniques; (2) to establish indications
and contra-indications for use of SPD In treating pressure ulcers; and (3) to develop a
noninvasive, clinically usable optical digitizer and associated software for measurement of
wound geometry for standardized quantitative assessment and longitudinal monitoring of wound
healing.
RESEARCH METHODS: 120 patients with stage III or IV pressure ulcers meeting the project
selection criteria will be recruited for the project. Patients will be randomly assigned in
a 3:1 (SPD to WTMD) ratio to either the control group receiving 0.9% normal saline
wet-to-moist wound dressing and treatment, or to the subatmospheric pressure dressing group.
All subjects selected will be further stratified according to degree of wound severity,
nutritional status, and evidence of wound infection. The WTMD group will receive 0.9% NS
moistened gauze applied to the wound, which will be changed every 8 hours. The SPD group
will receive SPD dressing with the VACTM system set at a constant subatmospheric pressure of
negative 125 mmHg. The SPD device and dressing will be left in place and changed every
Monday, Wednesday, and Friday. The subjects' pressure ulcers will be measured on day 0 and
then on a weekly basis. Ulcer surface shape, area, and coloration will be recorded with a
digital camera and also by tracing the ulcer perimeter on a flexible translucent plastic
film with grid overlaid on the wound. In addition, an optical laser scanner will used to
record ulcer shape, area, and coloration, and body/limb segmental volume in the region of
the wound. Volume will also be measured using alginate wound impressions to form RTV
silicone molds for fluid displacement measurement. The molds of the wounds will also be
optically digitized and wound perimeter, topical surface area, total 3-D surface area, and
volume calculated using computer image processing, planimetry, and volumetry software
developed in the project. Local body/limb segment volume will also be calculated to monitor
edematous fluctuations. Based on these measurements, the wound responses will be scored as
described in Table 2 after one month or at the time of the patient's withdrawal from the
study. The association between response level and treatment type will be analyzed using
Chi-square test of association. Mantel-Haenszel Chi-square and logistic regression will be
used to control for prognostic variables.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02652754 -
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
|
Phase 1 | |
Completed |
NCT01070433 -
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Diabetic Foot Ulcers
|
Phase 2 | |
Completed |
NCT00971048 -
Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds
|
N/A | |
Terminated |
NCT00762138 -
The AutoloGel™ Post-Market Surveillance (TAPS) Program
|
N/A | |
Completed |
NCT00578604 -
Non-Invasive Assessment of Wound Healing With Optical Methods
|
N/A | |
Completed |
NCT05417425 -
Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers
|
Phase 1 | |
Completed |
NCT02631512 -
Evaluation of Woulgan in Diabetic Foot Ulcer
|
Phase 4 | |
Terminated |
NCT01816633 -
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT02222376 -
Effect of Topic Pirfenidone in Diabetic Ulcers
|
Phase 3 | |
Completed |
NCT01454401 -
LeucoPatch™ Study A Multicenter Study on the Effect of LeucoPatch™ in Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT01221207 -
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
|
N/A | |
Withdrawn |
NCT01105884 -
Clinical and Cost Effectiveness of Different Dressing Materials in Diabetic Foot Ulcers
|
N/A | |
Completed |
NCT01291160 -
Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers
|
Phase 2/Phase 3 | |
Completed |
NCT00536744 -
Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers
|
Phase 3 | |
Terminated |
NCT00316537 -
Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers
|
Phase 1/Phase 2 | |
Completed |
NCT00013299 -
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
|
Phase 2 | |
Completed |
NCT00013286 -
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
|
Phase 2 | |
Terminated |
NCT02667327 -
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
|
Phase 3 | |
Not yet recruiting |
NCT00916292 -
Safety Study of Topical Human FGF-1 for Wound Healing
|
Phase 1 | |
Completed |
NCT01154374 -
A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)
|
Phase 2 |